The need for new therapeutic agents: what is the pipeline?
about
Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: a possible alternative in the treatment of non-nosocomial infections.A comparative study on the cost of new antibiotics and drugs of other therapeutic categoriesPeptidoglycan hydrolase fusions maintain their parental specificitiesEvaluation of the medicinal use of clay minerals as antibacterial agents.Hepatoprotective and antibacterial activity of Lippia nodiflora Linn. against lipopolysaccharides on HepG2 cells.A synthetic congener modeled on a microbicidal domain of thrombin- induced platelet microbicidal protein 1 recapitulates staphylocidal mechanisms of the native moleculeAntimicrobial and antioxidant flavonoids from the leaves of Oncoba spinosa Forssk. (Salicaceae)Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections.Synergistic interactions of methanolic extract of Acacia mearnsii De Wild. with antibiotics against bacteria of clinical relevanceAntibiotics and the ribosome.Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.Broad-spectrum in vitro antibacterial activities of clay minerals against antibiotic-susceptible and antibiotic-resistant bacterial pathogensBiologically active, synthetic ion transporters.Synthetic, biologically active amphiphilic peptidesUpdate on the appropriate use of linezolid in clinical practiceCurrent challenges in treating MRSA: what are the options?Novel acyl phosphate mimics that target PlsY, an essential acyltransferase in gram-positive bacteria.Plant antimicrobial agents and their effects on plant and human pathogensInsusceptibility to disinfectants in bacteria from animals, food and humans-is there a link to antimicrobial resistance?Ethanolic extracts of Tinospora cordifolia and Alstonia scholaris show antimicrobial activity towards clinical isolates of methicillin-resistant and carbapenemase-producing bacteria.Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cellsPartial purification and characterization of an antimicrobial activity from the wood extract of mangrove plant Ceriops decandra.Antibacterial activity of curcumin via apoptosis-like response in Escherichia coli.Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureusEfficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice.Synthesis and antimicrobial activity of some new hydrazone-bridged thiazole-pyrrole derivatives.Synergistic Effect of Diallyl Sulfide With Zinc Oxide Nanorods: A Novel and Effective Approach for Treatment of Acute Dermatitis in Model Animals.Evaluation of combination effects of ethanolic extract of Ziziphus mucronata Willd. subsp. mucronata Willd. and antibiotics against clinically important bacteria
P2860
Q21254662-4267DC86-2F25-42B0-A94C-2707167F47A1Q28469093-68821EC3-B6FC-4BD0-9C9E-ACD23A7EB7A9Q30446323-EA8AE39F-C28B-47EE-908B-D53BC980DB37Q33995558-4E380B29-A6F4-4DE4-9191-832B00E6C0EFQ35086846-1510F8A1-7770-4CBB-8E16-6329B736FE8EQ35127813-BF3B6C26-78E4-4553-95E6-EDD09B77B138Q35584001-A869E4A5-BD0F-4A64-86DB-CB68A31B1B58Q35876393-843181B1-B057-46F4-A9B1-D265AB4B05F8Q36197342-81CE2C64-8173-4CBB-B51F-476BCBA26106Q36428625-6EE6B0E6-405D-4106-A02A-83351371EEC2Q36548708-F6EFB486-D89E-421E-941A-B40382450F52Q36700223-670DDFAD-807C-4B48-AF91-A63541FB0908Q36723235-E4E1AC23-8AB9-49A5-89AF-5C69DD4CB3D5Q36859083-EA19B944-A6BA-4203-B67A-752021E5BDA5Q37116859-AAF02BB0-7C66-4691-A225-8CDA45802C14Q37291338-E172E759-B39C-4A06-9748-4952771D14E1Q37292453-7DF468D4-C92C-4E32-9D39-8982B1D5AE32Q37683439-62B88877-A117-4F0A-B456-CC5A697033C6Q38308385-426A01B5-D2B2-45E1-BF86-CBF5238FCC5AQ39002550-56D1A821-520F-4289-9F0E-1AB827948EAEQ39584994-D8FDCBAF-2BF4-4C5C-B9E3-DA1C2F719DA9Q39899067-F2D9574D-C707-4A0A-ABA1-AC8B419D5B8DQ39934500-99F2430F-6267-4597-914D-1C26A8440636Q42624603-2AC7BDC9-B185-488C-860D-38119E8F59EEQ43259028-8FC99075-5F7A-4D90-8FA0-8EB8FBD0D451Q47679932-6EF2B9D1-5CB5-45DC-A0AA-7E07EAD1D9E3Q53688735-4612F0FC-7EFB-48E1-8FF9-6EF9E5ABDC15Q59034494-4B4BE001-5A80-4278-AA3E-6955AC489375
P2860
The need for new therapeutic agents: what is the pipeline?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The need for new therapeutic agents: what is the pipeline?
@ast
The need for new therapeutic agents: what is the pipeline?
@en
type
label
The need for new therapeutic agents: what is the pipeline?
@ast
The need for new therapeutic agents: what is the pipeline?
@en
prefLabel
The need for new therapeutic agents: what is the pipeline?
@ast
The need for new therapeutic agents: what is the pipeline?
@en
P1476
The need for new therapeutic agents: what is the pipeline?
@en
P2093
P356
10.1111/J.1469-0691.2005.01141.X
P478
11 Suppl 3
P577
2005-05-01T00:00:00Z